aTyr Pharma, Inc. ATYR
3.69 USD -0.39 (-9.56%)
Regular-session close
3.70 +0.01 +0.27%
After hours · Nov 19, 4:12 PM ET
3.69 Day range 4.21
3.69 52-week range 44.40
- YTD
- -88.22%
- 1 year
- -86.33%
Ownership
- Institutions 63.2%
- Insiders 2.16%
- Public and other holders 34.7%
Held by insiders 2.16%
Held by institutions 63.15%
Float held by institutions 64.54%
Institutions 62
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Federated Hermes, Inc. | 17.47% | 14,666,600 | 50.16M | Sep 29, 2024 |
| FMR, LLC | 13.54% | 11,369,429 | 38.88M | Sep 29, 2024 |
| Vanguard Group Inc | 3.56% | 2,987,578 | 10.22M | Sep 29, 2024 |
| Tikvah Management LLC | 2.93% | 2,460,833 | 8.42M | Sep 29, 2024 |
| Logos Global Management LP | 2.38% | 2,000,000 | 6.84M | Sep 29, 2024 |
| Checkpoint Capital L.P. | 2.07% | 1,736,477 | 5.94M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Federated Hermes Kaufmann Fund | 9.35% | 7,850,000 | 26.85M | Jul 30, 2024 |
| Federated Hermes Kaufmann Small Cap Fund | 7.89% | 6,620,000 | 22.64M | Jul 30, 2024 |
| Fidelity Growth Company Fund | 3.44% | 2,887,967 | 9.88M | Oct 30, 2024 |
| Fidelity Select Portfolios - Biotechnology | 3.01% | 2,524,394 | 8.63M | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 2.46% | 2,065,835 | 7.07M | Sep 29, 2024 |
| Fidelity Growth Company K6 Fund | 1.25% | 1,052,049 | 3.60M | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROADFOOT JILL MARIE | Chief Financial Officer | Sale | Feb 5, 2024 | 20,821 |
| CLARKE JOHN K. | Director | Conversion of Exercise of derivative security | Apr 25, 2023 | 19,797 |
| COUGHLIN TIMOTHY P | Director | Purchase | May 29, 2024 | 0 |
| DENYES NANCY | General Counsel | Purchase | Jun 4, 2024 | 22,267 |
| GROSS JANE A | Director | Conversion of Exercise of derivative security | Apr 25, 2023 | 6,000 |
| LUCAS SVETLANA | Director | Conversion of Exercise of derivative security | Apr 25, 2023 | 6,000 |
